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Abstract
Background Long-term CT follow-up studies are required in
pediatric patients who have received intraoperative radiation
therapy (IORT) and external beam radiation therapy (EBRT)
to assess vascular toxicities and to determine the exact
complication rate.
Objective To analyze with CT the effects of radiation therapy
(RT) on the growth of the aorta in neuroblastoma patients.
Materials and methods Abdominal CT scans of 31 patients
with intraabdominal neuroblastoma (stage II–IV), treated with
RT (20 IORT±EBRT, 11 EBRT alone), were analyzed
retrospectively. The diameter of the abdominal aorta was
measured before and after RT. These data were compared to
normal and predicted normal aortic diameters of children,
accordingtothemodelofFitzgerald,DonaldsonandPoznanski
(aortic diameter in centimeters=0.844+0.0599×age in years),
and to the diameters of a control group of children who had not
undergone RT. Statistical analyses for the primary aims were
performed using the chi-squared test, t-test, Mann-Whitney
test, nonparametric Wilcoxon matched-pairs test and analysis
of variance for repeated measures. Clinical files and imaging
studies were evaluated for signs of late vascular complications
of neuroblastoma patients who had received RT.
Results The mean diameter before and after RT and the
growth of the aorta were significantly lower than expected
in patients with neuroblastoma (P<0.05 for each) and when
compared to the growth in a control group with normal and
nonirradiated aortas. Among the patients who had received
RT, there was no difference due to the type of RT. Seven
patients from the IORT±EBRT group developed vascular
complications, which included hypertension (five), middle
aortic syndrome (two), death due to mesenteric ischemia
(one) and critical aortic stenosis, which required aortic
bypass surgery (two).
Conclusion Patients with neuroblastoma who had received
RT showed impaired growth of the abdominal aorta.
Significant long-term vascular complications occurred in
seven patients who received IORT±EBRT. Thus, CT
evaluation of patients with neuroblastoma who receive RT
should include not only reports of changes in tumor
extension, but also documentation of perfusion, and the
size and growth of the aorta and its branches over time.
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Neuroblastoma is the most common extracranial solid
tumor in children and often presents as a large abdominal
mass that encases major blood vessels [1–3]. Treatment of
neuroblastoma depends on clinical and biological risk
factors. Multimodality therapy, including surgery, chemo-
therapy and adjuvant radiotherapy, followed by myeloabla-
tive therapy and peripheral blood stem cell transplantation
appear most effective in the treatment of high-risk disease
[4, 5].
Adjuvant radiotherapy has proven effective for local
control in the treatment of high-risk neuroblastomas (stage
III and IV) [6, 7]. The role of adjuvant radiotherapy
continues to evolve as physicians balance treatment benefits
against long-term side effects, which are particularly severe
in children [6–10]. External beam radiation therapy (EBRT)
has sometimes been supplemented or replaced by intra-
operative radiation therapy (IORT) in these patients. IORT
allows the administration of high-dose radiation to a limited
field, thereby maximizing tumoricidal radiation effects and
minimizing toxicity to normal tissue [11]. However, since
neuroblastomas often encase abdominal vessels, these
vessels are also exposed to relatively high radiation doses.
The majority of reports on IORT are limited to short- and
intermediate-term follow-up studies in adults and canine
models [12–16]. However, several studies have demon-
strated the efficacy of IORT for achieving local control in
children [7, 11, 17–19]. Canine models have demonstrated
deleterious effects of IORT on the aorta and branch arteries
including marked vascular narrowing in long-term follow-
up studies exceeding 5 years [13, 20].
We recently encountered three children with intraabdo-
minal high-risk neuroblastoma at our institution who
developed a severe middle aortic syndrome (MAS) several
years after successful multimodal treatment of their neuro-
blastoma (surgery, chemotherapy and IORT). The MAS led
to death due to mesenteric ischemia in one patient and
required an arterial bypass surgery in the other two patients.
MAS is a clinicopathological definition referring to isolated
disease of the abdominal aorta comprising significant
proximal tubular narrowing with stenosis that results in
uncontrollable hypertension and deteriorating renal function
[21–23].
To the best of our knowledge, no studies exist that have
evaluated the effects of IORT and/or EBRT on the
abdominal aorta and tributaries in patients with neuroblas-
toma. Thus, the purpose of our study was to analyze with
CT the effects of multimodality therapy including IORT,
with or without EBRT, or EBRT alone on the growth of the
aorta in patients with intraabdominal neuroblastoma and to
determine if vascular complications occurred in these
patients.
Materials and methods
The Committee of Human Research at our institution
approved this retrospective study and did not require
patient informed consent. All investigators complied with
Health Insurance Portability and Accountability Act
regulations.
Patients
In a retrospective evaluation of our pediatric oncology
patient population, we investigated the abdominal aorta of
patients with neuroblastoma treated with radiation therapy
(RT) on CT scans. The inclusion criteria for this study were
patients with neuroblastoma and an intraabdominal primary
tumor who were treated with IORT and/or EBRT and who
had available CT imaging before RT. A total of 69
neuroblastoma patients treated consecutively between
1993 and 2005 received RT, but 25 had to be excluded
due to lack of available imaging studies. A total of 44
patients had at least one CT scan available, including 29
who had IORT with or without EBRT, and 15 who had
EBRT without IORT (Table 1), and 31 of these 44 (10
IORT, 10 IORT + EBRT, 11 EBRT) had imaging studies
before RT and were thus analyzed; of these, 25 had scans
both before and after RT.
IORT and EBRT
The 20 patients with pre-RT scans receiving IORT were
treated between 1993 and 2004 with only two treated prior
to 1998. Treatment from 1998 occurred in the operating
room at the time of primary surgical resection employing a
dedicated mobile linear accelerator (Mobetron; Intraop
Medical, Sunnyvale, CA). Lucite or aluminum cones, 2.1
to 9.5 cm in interior diameter, were used to deliver electron
beams, with energies ranging from 4 to 16 MeV. The target
volume was encompassed within the 80–90% isodose line.
To ensure coverage of the entire tumor bed and all areas
Table 1 Numbers of evaluated patients who underwent IORT with or
without EBRT (IORT±EBRT) or EBRT alone in relation to the
availability of CT scans. Of the 44 patients with at least one CT scan
available, 31 with pre-RT imaging and 25 with both pre- and post-RT
imaging were included in the analyses
RT cohort Scan availability Total
Pre- and
post-RT
Pre-RT
only
Post-RT
only
IORT±EBRT 18 2 9 29
EBRT 7 4 4 15
Total 25 6 13 44
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separate IORT fields were used. For the two patients treated
in 1993 and 1997, respectively, RT took place in the
Radiation Oncology Department. The patients were trans-
ported at the time of surgery or reopened on the following
day. IORT doses for all patients ranged from 10 to 12.5 Gy,
with 90% of the patients receiving 10 Gy. Shielding of
normal tissues not at risk of disease involvement was
accomplished by physical exclusion from the radiation
field, or by the use of lead sheets when necessary. Patients
receiving EBRT were treated during a concurrent time
period between 1997 and 2005. EBRT doses ranged from
18 to 24 Gy with 72% of patients receiving 21.6 Gy.
Radiation doses were comparable to those reported else-
where; however, the threshold dose of blood vessels is
unknown [7].
CT technique
CT examinations were performed with three different
helical CT scanners (General Electric Medical Systems,
Fairfield, CT). The protocol depended upon the age and
weight of the pediatric patient, with the following approx-
imate value ranges: 80–120 kVp, 60–100 mAs, helical slice
thickness 3.75–5 mm, pitch 0.562:1–1.75:1, continuous
table motion speed 13.75–27.50 mm/rotation, and recon-
struction index 3.75–5 mm. The patients received 2 cm
3/kg
of intravenous Omnipaque 300 (GE Healthcare/Amersham
Health, Princeton, NJ).
CT imaging evaluations
The CT imaging studies selected from the pre- and post-RT
scans were those with the closest and latest dates, respec-
tively. For two patients, who were treated with EBRT prior
to IORT, the pre-RT CT scan was obtained after the EBRT
but before the IORT. Two radiologists in consensus
measured the diameter of the abdominal aorta on axial CT
scans during the arterial phase of enhancement at four
specific locations: primary tumor, celiac artery, superior
mesenteric artery and renal arteries. The observed aortic
diameters were compared to predicted values for normal
children according to the model developed by Fitzgerald et
al. [24] whereby the normal aortic diameter is a linear
function of age: aortic diameter in centimeters=0.844+
0.0599×age in years. The observed and predicted changes
in aortic diameter at the primary tumor level before and after
RT were determined for the following subsets: (1) patients
who received IORT with or without EBRT (IORT±EBRT)
and (2) patients who received EBRT alone (EBRT).
In addition, the diameters of the celiac, superior
mesenteric, and renal arteries were evaluated qualitatively
on the axial CT scans as normal, focally narrowed, or not
visible. A focal narrowing was defined as a decrease in the
diameter of more than 50% with respect to distal portions
of the same vessel (in case of visceral branches) or
compared to the contralateral side (renal vessels). A
quantitative measurement of these branches was not
possible because of the small diameters and different
orientations of these vessels among studies.
Statistical methods
The time between CT scans and RT was estimated using the
Kaplan-Meier product limit method with distributions be-
tweenRTgroupscomparedwiththe log-ranktest.Toevaluate
pre-RT comparability of the two RT patient groups, a chi-
squared test for categorical variables, t-test for independent
groups for continuous variables, and the Mann-Whitney test
to compare distributions (e.g., age) were performed. The
distributions of paired measurements (e.g., predicted and
observed aortic diameter) were compared using the paired
t-test and the nonparametric Wilcoxon matched-pairs test.
Pre-RT differences between the observed and predicted
aortic diameter at four locations (tumor site, celiac, superior
mesenteric, and renal arteries) were compared using analysis
of variance (ANOVA) for repeated measures.
The predicted values of aortic growth were determined
from a validated equation expressing growth as a linear
function of age [1]. For comparison, the predicted and
measured values of aortic growth were compared to an age-
matched control group of 36 children (19 boys, 17 girls) who
underwent a CT study for a nononcologic pathology
(indications: abdominal pain, appendicitis) and who did not
undergo abdominal irradiation. Because predicted values are
based upon a linear model, the mean value as a summary
measure of a difference or change in growth is more
appropriate to present than the median, which is more
appropriate for the small samples in this study. Therefore, the
data were analyzed using both parametric and nonparametric
methods and statistical significance was determined when
both tests resulted in a probability value less than 0.05. For
the results presented, the parametric and nonparametric
methods always agreed in determining significance and the
parametric probability values for tests of means are
presented.
Results
Patient characteristics and RT
The two patient groups (IORT±EBRT, and EBRT alone)
had comparable disease features at the time of diagnosis
and similar follow-up durations from diagnosis (Table 2).
The group treated with IORT±EBRT included a greater
1196 Pediatr Radiol (2009) 39:1194–1202number of patients who were younger than 24 months at
diagnosis (P=0.06), at the time of the pre-RTscan (P=0.07),
and at the time of RT (P=0.07), compared with the group of
patients treated with EBRT alone. Although these border-
line statistically significant differences were observed when
the patients were categorized according to age (<24 vs.
>24 months), there was no difference in the overall
distributions of age between the RT groups.
For each RT group, the measured mean aortic diameter
was significantly lower than the predicted normal value and
the normal aorta of nonirradiated control patients
(P<0.0001 for each comparison). For both RT groups, all
pair-wise comparisons among the four aortic measurements
as well as the predicted normal values were highly
correlated (P<0.001) for each comparison for the entire
study sample and within each RT subset. There was no
significant difference in the mean prescan measurements
between the two RT groups overall at each of the four
locations (overall ANOVA for repeated measures P=0.71;
P>0.44 for each location). These pre-RT measurements
were obtained prior to any RT, so correlations at the four
measurement locations for the entire study sample of
irradiated patients could be evaluated together. Therefore,
the remainder of this analysis focuses on aortic measure-
ments at the primary tumor site.
Pre-RT aortic diameter
The median time from the pre-RT CT scan to IORT±EBRT
was 1.1 months with 19 of 20 patients treated within
4.5 months of the baseline scan. The median duration from
the pre-RT scan to EBRT was 0.5 months with 8 of 11
patients treated within 1 month of the baseline scan. The
mean observed aortic diameter was 0.74 cm (range 0.40–
1.30 cm) before treatment with IORT±EBRT and 0.93 cm
(range 0.51–1.76 cm) before treatment with EBRT alone.
The aortic diameter of both groups was significantly
smaller than the predicted normal aortic diameter (mean
difference: IORT±EBRT −0.37, P<0.0001; EBRT −0.27,
P<0.0001; Fig. 1).
Post-RT aortic diameter and aortic growth
For the 25 patients with both pre- and post-RT CT scans, the
median CT follow-up time between the pre-RT and post-RT
CTscansdidnotdiffersignificantlybetweentheIORT±EBRT
group (median 22.1 months, range 0.4–72.5 months) and the
EBRT group (median 27.8 months, range 9.2–70.6 months).
There was also no difference in age at the time of the post-
RT scan (median 5.7 years, range 1.3–22.6 years in the
IORT±EBRT group; median 6.6 years, range 3.2–25.9 years
in the EBRT group) so that a similar distribution of the
observed aortic diameters would be expected for the two RT
groups.
The observed post-RTaortic diameter at the primary tumor
site was significantly smaller than the predicted value for both
the IORT±EBRT group (P<0.0001) and the EBRT group
(mean P=0.003). The post-RT mean predicted aortic diam-
eter was 1.25 cm (range 0.92–2.20 cm) for the IORT±EBRT
group and 1.38 cm (range 1.03–2.40 cm) for the EBRT
group. The post-RT mean observed aortic diameter was
0.80 cm (range 0.50–1.48 cm) for the IORT±EBRT group
and 0.82 cm (range 0.54–1.26 cm) for the EBRT group.
There was no significant difference between the two RT
groups (P<0.05; Fig. 1).
Patients who received RT showed no significant
change in aortic diameter between the pre-RT and post-RT
CT scans (mean change: IORT±EBRT 0.03 cm, P=0.39;
EBRT −0.10 cm, P=0.22; Fig. 2).
Table 2 Patient and disease characteristics at diagnosis
IORT ± EBRT
(n=20)
EBRT
(n=11)
Follow-up from diagnosis (months)
Median 23.5 19.8
Range 3.1–122.0 10.9–97.0
Male, n (%) 14 (70%) 8 (73%)
Age at RT (months)
Mean 54.7 74.6
Median 32.9 54.8
Range 10.9–247.4 25.1–263.0
Age groups (n)
<24 months 5 0
>72 months 4 4
Stage, n (%)
a
II 1 ( 5%)
III 5 (25%) 4 (36%)
IV 13 (65%) 7 (64%)
IVs 1 ( 5%) –
N-MYC amplification, n (%)
Yes 3 (15%) 4 (36%)
No 8 (40%) –
Unknown 9 (45%) 7 (64%)
Surgery, n (%)
Gross total resection 14 (70%) 9 (82%)
Subtotal resection 6 (30%) -
Unknown – 2 (18%)
Pathologic lymph node involvement, n (%)
Yes 7 (35%) 4 (36%)
No 2 (10%) 1 ( 9%)
Unknown 11 (55%) 6 (55%)
Hematopoietic Stem Cell
Transplant, n (%)
13 (65%) 10 (91%)
aInternational Neuroblastoma Staging System.
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Abnormalities of the vascular branches of the aorta
were documented after RT in five patients treated with
IORT+EBRT and in two patients treated with EBRT.
Patients treated with IORT±EBRT demonstrated narrowing
of the celiac trunk (one patient), superior mesenteric artery
(two), and renal arteries (two) as well as asymmetric
perfusion of the kidneys (one). Three of these patients had
clinical symptoms of MAS. Two patients treated with
EBRT showed a narrowing of the celiac trunk (one) and
asymmetric perfusion of the kidneys (two). However, at the
time of this report neither of these two patients had clinical
signs or symptoms referable to these radiographic findings.
Clinical follow-up after RT
At the time of this report, 8 of the 20 patients treated with
IORT±EBRT had shown recurrence and had died. Among
the 11 patients treated with EBRT, 7 had shown recur-
rence, of whom 5 have died. Seven patients treated with
IORT±EBRT had one or more clinical long-term compli-
cations that included hypertension (five), MAS (three),
and death due to mesenteric ischemia (one; Figs. 3 and 4).
The one patient who died of mesenteric ischemia did not
Fig. 1 Difference between observed and predicted aortic diameter
for patients treated with EBRT (hatched bars)o rI O R Tw i t ho r
without EBRT (IORT±EBRT, solid bars). Before RT, only one
patient in the entire study sample had an aortic diameter at least as
large as the predicted value. All other RT patients showed
significantly smaller aortic diameters than predicted (P<0.0001).
After RT, the aortic diameters were smaller than predicted for all
patients (IORT±EBRT P<0.0001, EBRT P=0.003). Only two
patients treated with IORT+EBRT had measurements within
0.2 cm of their predicted value. The discrepancy between observed
and predicted aortic diameters increased after RT
Fig. 2 Aortic diameters before and after RT. There are two bars for
each patient indicating the observed (solid bars) and predicted normal
(hatched bars) changes in aortic diameter. The negative bars indicate a
decrease in aortic diameter. Both RT groups showed significantly less
growth of the aorta than expected (P<0.05)
1198 Pediatr Radiol (2009) 39:1194–1202Fig. 3 Imaging studies of a girl with stage IV neuroblastoma who
developed hypertension and abdominal pain 5 years after right
nephrectomy, chemotherapy and IORT. a Sagittal contrast-enhanced
CT image prior to treatment shows a normal caliber of the abdominal
aorta (white arrow), which is encased by tumor. b Gadolinium-
enhanced abdominal MR angiogram 5 years later demonstrates a
markedly narrowed infrarenal abdominal aorta to 3 mm in diameter. c
Conventional angiography confirms narrowing of the abdominal aorta
(arrow) and proximal left renal artery (arrowhead). d Lateral view
from conventional angiography shows additional narrowing of the
proximal superior mesenteric artery (arrow)
Fig. 4 Imaging studies of a boy with stage IV neuroblastoma who
developed hypertension and severe bowel ischemia 12 years after
treatment with surgery, chemotherapy, IORT, total body irradiation
and bone marrow transplantation. The patient underwent aortic bypass
surgery, but died shortly afterwards from complications of mesenteric
ischemia. a–c MR angiography and conventional angiography show
complete occlusion of the superior and inferior mesenteric arteries as
well as a complete occlusion of the right renal artery (arrowhead) near
their origins from the abdominal aorta. There is also a focal stenosis of
the celiac trunk near its origin with complete occlusion of the splenic
artery. The caliber of the infrarenal aorta is mildly decreased (arrow).
d Axial T1-W MR image after intravenous Gd-DTPA injection shows
a large right infarct of the right kidney as a result of occlusion of the
right renal artery. e CT image demonstrates extensive pneumatosis of
small bowel loops due to mesenteric ischemia
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and the diagnosis of MAS was 9 years (range 5 to
14 years). All three patients with MAS underwent
aortorenal bypass surgery and one patient also required a
thoracic to infrarenal aortic bypass. All three patients with
MAS demonstrated growth deformities of the upper
lumbar vertebrae (Fig. 5). Of the seven patients with
complications, four were less than 24 months old and two
were older than 72 months at the time of IORT±EBRT.
Therefore, there is no clear evidence of a difference in
complications due to age at the time of IORT±EBRT. No
patient in the EBRT group reported clinical symptoms of
MAS or other signs of visceral ischemia. There was no
apparent association between t h ed e g r e eo fa o r t i cg r o w t h
inhibition and the occurrence of clinical complications.
Discussion
Both groups of patients treated with RT (IORT±EBRT and
EBRT) had significantly smaller measured aortic diameters
thanthepredictedage-adjustednormalaorticdiametersbefore
RT. Patients with neuroblastoma who received abdominal RT
had a significant decrease in aortic growth. Several patients
treated with IORT±EBRT developed serious complications,
including MAS. MAS is a rare entity most prevalent among
adolescents and young adults [22, 25]. Sen et al. [23]w e r e
the first to describe it in 1963 as a severe narrowing of the
proximal abdominal aorta. Clinically the main presenting
symptom is hypertension and symptoms may variably
include severe headache, nosebleeds, chest pain, cardiac
failure and kidney failure [26]. The etiology remains
unknown [22, 25, 26]. The histology of MAS is described
as nonspecific dysplastic, fibrotic changes lacking signs of
inflammation, or necrosis [27, 28].
The biological effect of radiation on the vasculature is
well documented for the coronary arteries and microvascu-
lature, but otherwise is not well documented [29, 30].
Gillette et al. [20] described the response of canine aorta
and branch arteries to experimental IORT and reported a
narrowing of the aorta on aortography and a thickening of
the intima on histopathology, occurring more than 5 years
Fig. 5 Imaging studies of a girl with stage IV neuroblastoma who
developed hypertension and abdominal pain 7 years after tumor
surgery, chemotherapy and IORT. a, b Axial contrast-enhanced CT
angiograms (a) and 3-D reconstruction (b)s h o wa ne x t r e m e l y
narrowed infrarenal aorta (arrow), as well as absent celiac, superior
mesenteric and left renal arteries. The left kidney is not visible due to
marked atrophy (a open arrow). Multiple abdominal collateral vessels
are visualized (arrowhead). The right renal artery demonstrates mild
proximal stenosis. c Coronal reformat shows additional deformities of
the lumbar vertebrae (arrow). d MR angiogram after treatment with
right renal artery angioplasty and right aortorenal bypass surgery
shows a widely patent aortic bypass graft, conduit and anastomoses,
and persistent absent flow in the celiac trunk; hepatic artery flow is
maintained via collaterals
1200 Pediatr Radiol (2009) 39:1194–1202after IORT [30]. From these studies, it is evident that
follow-up time is an important factor when fully assessing
toxicities of IORT and EBRT.
As a result of continuing therapeutic advances, children
with cancer are surviving longer than in previous decades,
rendering long-term follow-up studies essential for optimal
treatment and continued care. Pediatric studies reviewing
the effects of IORT in children involve follow-up ranges of
6 to 101 months after RT. These reports suggest that IORT
improves local control of disease with high doses of
radiation and that complications at doses used were trivial.
It should be noted that the populations studied were
small and follow-up periods relatively short [7, 11, 12, 14,
17, 18]. Of note, there was no radiological documentation
in the aforementioned studies of MAS. Our findings are in
accordance with reports of a patient with renal artery
stenosis, a patient with mesenteric artery ischemia, and a
patient with hypertension after IORT for neuroblastoma [7,
11, 12]. In the adult population, analyses of side effects in
patients surviving more than 5 years after IORT have
identified significant vascular occlusion resulting in irre-
versible functional damage requiring aggressive manage-
ment [15, 31]. CT imaging studies were used because all
patients underwent CT at diagnosis and subsequently to
monitor disease progression and/or therapeutic response,
thus allowing this retrospective review. A gold-standard
modality to measure the abdominal aorta does not exist. CT
and US are commonly used; however, they are both subject
to significant interobserver variability. Research evaluating
the size of the pediatric aorta is extremely limited and there
are no recognized age-adjusted reference values for either
CT or US. Fitzgerald et al. [24] have conducted the only
study that has evaluated the pediatric aortic diameter on CT.
Several US studies have shown independent pediatric
abdominal aortic diameter nomograms in relation to various
factors such as age, gender, weight, height, body mass
index and body surface area without consensus on
variations in relation to sex.
Several limitations of this retrospective study have to be
recognized. First, the exact etiology of the decreased aortic
size and growth was uncertain, although RT is certainly
plausible; yet other confounding variables must be consid-
ered. The aggressive nature of the tumor itself may have
contributed to the observed decrease in pre-RT aortic
diameter, and residual tumor after gross surgical resection
may have caused the subsequent decreased rate of aortic
growth. However, MAS was documented in four patients in
remission. In addition, a specific biochemical profile/growth
factor, chemotherapy, surgery, hematopoietic stem cell
transplantation and/or unknown pathologic contributing
factor could have contributed to the impaired aortic size
and growth, and development of MAS. Evaluation of aortic
size and growth in a matched cohort of neuroblastoma
patients not treated with RT would provide additional
information. Second, we could not determine a direct
correlation between the degree of decrease in aortic caliber
and vascular complications. This may have been due to
potential additional contributing factors such as impairments
at the level of major abdominal arteries or microvessels and
the small size of the study cohort. Conversely, some of our
results may describe complications not related to radiation or
may be confounded by additional therapeutic procedures
such as surgery. All patients who received IORT did so for
gross residual disease or for tumors deemed unresectable,
and so many had worse tumors, explaining the higher rate of
complications, i.e. these patients may have developed the
problems from the tumor and/or surgery itself. Finally, the
CT imaging protocol used was not defined and institutional
access to CT scans limited the cohort size and median
follow-up for aortic growth. A prospective large study of
comparable cohorts of patients as to the extent of disease
treated with designated radiation modalities and careful
uniform imaging at defined time points would be necessary
to answer some of these questions.
Medical management for MAS in the pediatric popula-
tion is preferred until the child has ceased growing so as to
prevent a second surgery to accommodate the growth. The
treatment of choice for MAS is now either a one-stage
reconstructive prosthetic or autologous venous surgical
arterial bypass graft.
In conclusion, limited aortic growth after RT in patients
with neuroblastoma diagnosed on CT scans may be the first
sign of MAS. Radiologists and clinicians should be aware
of the possibility of such a diagnosis and the important
consequences that arise in regard to patient management.
Long-term CT follow-up studies including coronal recon-
struction images are required in pediatric patients who
receive IORT and EBRT to assess potential toxicities and to
determine the exact complication rate.
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